Delivery Order SPE2DB22D3501-SPE2DB25FUZ33
Award Date
3/20/25
Potential Completion Date
4/10/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,259.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 400 mg vials of BENLYSTA, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical through December 31, 2025. The IDC enables DLA to efficiently procure a range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $12,595.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of 400 mg vials of the medication BENLYSTA. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,098.52, is for the delivery of BENLYSTA 400 MG vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 14, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,516.80 firm-fixed-price contract is for the supply of 120 mg vials of the pharmaceutical drug Benlysta. It has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a broad range of medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 400 MG VIALS. The $5,038.00 firm fixed price contract has a period of performance through November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical to provide a comprehensive range of medical commodities supporting...
The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,515.15 firm fixed-price delivery order is for the supply of 400 mg vials of the drug Benlysta, with a completion date of January 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,629.64 firm-fixed-price delivery order is for the provision of BENLYSTA 400 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a $2,275.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564318948 units of BENLYSTA 120 MG VIALS, with a period of performance through May 9, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the main...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,888.86 firm-fixed-price delivery order is for the supply of BENLYSTA 400 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...